- Filed
- Apr 25, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2019 · Apr 22, 2019 | 705.26M sh |
| Shares Diluted | Q1 2019 · Mar 31, 2019 | 720.5M sh |
| Shares Diluted | Q1 2019 · Mar 31, 2018 | 768.3M sh |
| Stock Repurchased | Q1 2019 · Mar 31, 2019 | $0 |
| Stock Repurchased | Q1 2019 · Mar 31, 2018 | $2.7B |
| Capex | Q1 2019 · Mar 31, 2019 | $69M |
| Capex | Q1 2019 · Mar 31, 2018 | $88M |
| Operating Cash Flow | Q1 2019 · Mar 31, 2019 | $1.48B |
| Operating Cash Flow | Q1 2019 · Mar 31, 2018 | −$325M |
| Cash And Equivalents | Q1 2019 · Mar 31, 2019 | $5.43B |
| Cash And Equivalents | Q1 2019 · Dec 31, 2018 | $4.23B |
| Cash And Equivalents | Q1 2019 · Mar 31, 2018 | $2.82B |
| Cash And Equivalents | Q1 2019 · Dec 31, 2017 | $7.01B |
| Stockholders Equity | Q1 2019 · Mar 31, 2019 | $8.17B |
| Stockholders Equity | Q1 2019 · Dec 31, 2018 | $6.16B |
| Stockholders Equity | Q1 2019 · Mar 31, 2018 | $5.17B |
| Stockholders Equity | Q1 2019 · Dec 31, 2017 | $6.92B |
| Current Liabilities | Q1 2019 · Mar 31, 2019 | $3.96B |
| Current Liabilities | Q1 2019 · Dec 31, 2018 | $4.06B |
| Total Liabilities | Q1 2019 · Mar 31, 2019 | $29.47B |
| Total Liabilities | Q1 2019 · Dec 31, 2018 | $29.32B |
| Current Assets | Q1 2019 · Mar 31, 2019 | $10.98B |
| Current Assets | Q1 2019 · Dec 31, 2018 | $9.07B |
| Total Assets | Q1 2019 · Mar 31, 2019 | $37.64B |
| Total Assets | Q1 2019 · Dec 31, 2018 | $35.48B |
| Eps Diluted | Q1 2019 · Mar 31, 2019 | $2.14 |
| Eps Diluted | Q1 2019 · Mar 31, 2018 | $1.10 |
| Eps Basic | Q1 2019 · Mar 31, 2019 | $2.20 |
| Eps Basic | Q1 2019 · Mar 31, 2018 | $1.13 |
| Sga Expense | Q1 2019 · Mar 31, 2019 | $773M |
| Sga Expense | Q1 2019 · Mar 31, 2018 | $864M |
| Operating Income | Q1 2019 · Mar 31, 2019 | $1.71B |
| Operating Income | Q1 2019 · Mar 31, 2018 | $218M |
| Cost Of Revenue | Q1 2019 · Mar 31, 2019 | $140M |
| Cost Of Revenue | Q1 2019 · Mar 31, 2018 | $135M |
| Revenue | Q1 2019 · Mar 31, 2019 | $4.03B |
| Revenue restated | Q1 2019 · Mar 31, 2018 | $3.54B |